iiinova — where your digital self keeps evolving

Devika Das,MD MSHQS @devikadasmd.bsky.social · 25/07/2025

Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury | Journal of Clinical Oncology ascopubs.org/doi/10.1200/... #lcsm #oncmeded #ClinicalDilemna

ascopubs.org

Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury

030

Devika Das,MD MSHQS @devikadasmd.bsky.social · 21/04/2025

HER2 in NSCLC is underrecognized & complex. Grateful to join @cor2edmeded.bsky.social with an expert path colleague to discuss timely testing and clinical utility—now targetable on/off clinical trials. Thanks @oncbrothers.bsky.social for the invite! #lcsm #oncMedEd cor2ed.com/lung-connect...

cor2ed.com

The HER2 diagnostic and treatment landscape in NSCLC: Episode 1 | COR2ED

This is the first episode of a two-part series on the HER2 diagnostic and treatment landscape in non-small cell lung cancer (NSCLC), hosted by the

051

Reposted by Devika Das,MD MSHQS

Lung Cancer Research Foundation @lcrf.org · 03/03/2025

LCRF was part of @ufhealthcancer.bsky.social U of Florida's 55th Annual Radiation Oncology Research Seminar on Feb. 28, with a panel on the importance of local control in #LungCancer. Ramesh Rengan, MD, PhD, FASTRO, (top left) was keynote speaker. @devikadasmd.bsky.social (top right) was a panelist.

Collage of 3 photos. Top left photo is keynote speaker Dr. Ramesh Rengan. Top right photo shows Natalie Reilly-Finch and Dr. Devika Das at a table for the Lung Cancer Research Foundation. Bottom photo is a group of 8 doctors.

052

Devika Das,MD MSHQS @devikadasmd.bsky.social · 09/01/2025

Sending my prayers and thoughts to everyone affected by the devastating fires in LA. 🙏🏽😔 Specifically within the cancer/ oncology community, if there is anything we can do to support our colleagues/patients do tag! #lcsm #LosAngelesFire

070

Devika Das,MD MSHQS @devikadasmd.bsky.social · 18/12/2024

The BEST part of my day is when I find a NGS report with a targetable mutation! What a time to practice thoracic oncology! #lcsm 🛑 All patients with lung cancer⭐️NEED ⭐️ comprehensive biomarker testing.

1122

Devika Das,MD MSHQS @devikadasmd.bsky.social · 25/11/2024

Could not agree more! Investment in high quality palliative care research and clinics/care delivery should be a requirement for all cancer program.

051

Devika Das,MD MSHQS @devikadasmd.bsky.social · 23/11/2024

All of the above! I needed a safe space but don’t want to limit myself to an echo chamber 🙏🏽

030

Devika Das,MD MSHQS @devikadasmd.bsky.social · 22/11/2024

www.lung.org/research/sta... As we reach the end of lung cancer awareness month, please take a moment to review state level score cards for your practice area in the US through this state of lung cancer report. #lcsm 🛑 We certainly have some work to do in Florida!

061